Weight-loss giant Novo Nordisk's shares rose over 5% on Friday to a high last touched in October, driven by "encouraging" early U.S. prescription data for its Wegovy pill, which the firm hopes will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results